Broadcom vs. Marvell: Which Custom AI Chip Stock Is the Better Buy?

Broadcom reported fiscal Q3 2026 revenue of $29.6 billion, up 86% year over year, as AI semiconductor revenue surged 221% to $16.7 billion; EPS rose 96% to $3.32. The company forecasts AI-chip revenue of $21.7 billion this quarter and projects annual AI-chip revenue could rise from $58 billion in fiscal 2026 to $115 billion in fiscal 2027 and $230 billion in fiscal 2028. Marvell is also growing, with fiscal Q2 2027 revenue up 37% to $2.74 billion, but its lower estimated custom-AI market share of 20%-25% versus Broadcom's projected 60% supports the article's preference for Broadcom on growth and valuation.

Analysis

The investable distinction is not simply ASIC exposure but control of the design-to-volume ramp. AVGO’s scale, packaging ecosystem, and embedded customer programs should produce superior operating leverage as AI silicon shifts from pilot deployments to repeatable cluster rollouts over the next 6-18 months. MRVL remains a higher-beta beneficiary, but its smaller base makes results more dependent on winning incremental programs and converting design wins into production revenue rather than merely participating in category growth.

The principal unpriced risk is hyperscaler concentration. Custom silicon lowers customers’ inference cost, but it also transfers purchasing power to a handful of buyers that can dual-source, delay tape-outs, or redesign internally; a single program slip can matter disproportionately for MRVL and eventually cap AVGO’s margin upside. Separately, ASIC adoption is not a clean zero-sum displacement of NVDA: training workloads, software portability, and rapid model changes preserve GPU demand, while ASICs are most economically compelling in stable, high-volume inference applications.

Consensus may be too focused on headline AI revenue trajectories and too little on the cost of sustaining them. Advanced packaging capacity, HBM availability, foundry allocation, and customer-specific engineering expense determine whether revenue growth converts to incremental gross margin; monitor quarterly AI gross-margin commentary and working-capital intensity rather than accepting multi-year company targets at face value. Near term, MRVL’s prior momentum leaves it more exposed to even a modest guide-down, whereas AVGO has a clearer 1-3 month catalyst path through evidence that custom-chip ramps are broadening beyond its largest programs.

Key Decisions for Investors

• Initiate a 6-12 month pair: long AVGO / short MRVL, dollar-neutral. The thesis is relative earnings-estimate durability and margin conversion rather than absolute AI demand; target 15-25% relative outperformance. Exit if MRVL reports material production ramps that lift its next-fiscal-year revenue outlook faster than AVGO’s AI revenue outlook, or if AVGO discloses a major customer program delay.
• Add AVGO on post-earnings volatility only if management confirms AI growth is supported by funded customer commitments and does not require a material increase in inventory or receivables. Use a 8-10% position stop from entry; the adverse case is concentration-driven order deferral and multiple compression despite continued reported growth.
• Maintain MRVL as a watch item rather than chase momentum. Upgrade only after independently verifiable evidence of incremental hyperscaler design-win conversion—such as revenue concentration improvement, backlog visibility, or a fiscal-2029 custom-silicon guide that exceeds current growth expectations; absent this, its valuation premium is vulnerable over the next 1-3 quarters.
• Do not short NVDA solely as an ASIC substitute trade. Instead, use NVDA relative weakness versus AVGO as a signal to assess whether inference economics are becoming a capital-allocation priority at GOOG and META; a broad reduction in GPU capex guidance, rather than ASIC revenue growth alone, would be the required catalyst for a bearish NVDA view.